Newsroom
Press releases
- 23/10/2024
DETECT Endometriosis Imaging Study Presented at EANM’24
Serac Healthcare Limited announces that its clinical partner, the Nuffield Department of Women’s and Reproductive Health at the University of Oxford, gave a presentation on the “Detecting Endometriosis expressed integrins using technetium-99m” (DETECT) imaging study at the European Association of Nuclear Medicine (EANM) annual congress taking place from 19-23 October in Hamburg, Germany
- 09/10/2024
Poster Presented at MICCAI on AI Joint Classification of Images using ⁹⁹ᵐTc-Maraciclatide
A poster was presented today at the annual conference of the Medical Image Computing and Computer Assisted Intervention Society (MICCAI) taking place from 6-10 October in Marrakesh, Morocco. The poster illustrates the latest methodology used in the ongoing research collaboration with King’s College London to develop AI tools to help clinicians read and interpret scans using 99mTc-maraciclatide.
- 08/10/2024
EANM DETECT Abstract Published and Presentation Details
An abstract on preliminary data from the DETECT “Detecting Endometriosis expressed integrins using technetium-99m” imaging study, has been published ahead of the upcoming congress of the European Association of Nuclear Medicine (EANM).
- 10/09/2024
Phase II PREDICT-ILD Imaging Study Commences in Interstitial Lung Disease
Serac Healthcare Limited and the University of Exeter today announce that the first patient has been scanned with a novel molecular SPECT imaging agent 99mTc-maraciclatide in a Phase II study titled ‘PRospective Evaluation of Interstitial Lung Disease progression with quantitative CT (PREDICT-ILD)’.
- 23/07/2024
Paper Accepted at MICCAI on AI Joint Classification of Images using ⁹⁹ᵐTc-Maraciclatide
A paper has been accepted for presentation at the annual conference of the Medical Image Computing and Computer Assisted Intervention Society (MICCAI) taking place from 6-10 October in Marrakesh, Morocco.
- 09/07/2024
Abstract Selected as Top Rated Oral Presentation at EANM on DETECT Study Evaluating ⁹⁹ᵐTc-Maraciclatide as a New Imaging Marker for Endometriosis
An abstract on preliminary data from the DETECT “Detecting Endometriosis expressed integrins using technetium-99m” imaging study, has been selected as a Top Rated Oral Presentation at the annual congress of the European Association of Nuclear Medicine (EANM) taking place from 18-23 October 2024 in Hamburg, Germany.
Events
Updates on our research programmes will be presented at the following conferences:
